A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 304
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PEA
Long Form : beta-phenylethylamine
No. Year Title Co-occurring Abbreviation
1975 Behavioral and electrophysiological effects of phenylethanolamine and 2-phenylethylamine. ---
1975 Phenethylamine in normal urine: failure to verify high values. TLC
1976 A simple fluorometric assay for type B monoamine oxidase activity in rat tissues. 5-HT, MAO
1976 Effect of beta-phenylethylamine and d-amphetamine on electrical self-stimulation of brain. d-A
1976 Evidence for a single catalytic binding site on human brain type B monoamine oxidase. MAO
1977 A fluorometric assay for beta-phenylethylamine in human urine. ---
1977 Characteristics of beta-phenethylamine self-administration by dog. ---
1977 Mass fragmentographic demonstration of low amounts of beta-phenylethylamine in human urine. ---
1977 Monoamine oxidase in developing chick retina. 5-HT, MAO
10  1978 A new animal model for schizophrenia: interactions with adrenergic mechanisms. ---
11  1978 Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. 5-HIAA, HE, OCT, PCS
12  1978 Attenuation of stereotyped behaviour by sex steroids. SB
13  1978 Concentrations of phenethylamine in dog following single doses and during intravenous self-administration. ---
14  1978 Disruption of conditioned avoidance behavior by n,n-dimethyltryptamine (DMT) and stereotype by beta-phenylethylamine (PEA): animal models of attentional defects in schizophrenia. DMT
15  1978 Effect of beta-fluorophenethylamine analogs on monoamine oxidase substrate preference. ---
16  1978 Lithium prevention of amphetamine-induced 'manic' excitement and of reserpine-induced 'depression' in mice: possible role of 2-phenylethylamine. ---
17  1978 Single dose and cross tolerance studies of beta-phenethylamine, d-amphetamine and LSD in the chronic spinal dog. ---
18  1978 The effects of lithium on phenylethylamine behavior in rats are counteracted by monoamine oxidase A and B inhibitors. ---
19  1978 The effects of phenylethylamine in rhesus monkeys. ---
20  1979 A comparison of the effects of acute and subacute administration of beta-phenylethylamine and d-amphetamine on mouse killing behavior of rats. ---
21  1979 Effect of beta-phenylethylamine on intraocular pressure. ---
22  1979 Phenylethylamine in paranoid chronic schizophrenia. ---
23  1979 Phenylethylamine in rhesus monkeys: interactions with alpha-methyl-para-tyrosine and l-dopa. AMPT
24  1979 Tolerance development to a disruptive effect of beta-phenylethylamine (PEA) on a learned behavior in rats. ---
25  1980 Beta-phenylethylamine and benzylamine as substrates for human monoamine oxidase A: A source of some anomalies? 5-HT, BZ, BzAO, MAO
26  1980 Direct effect of phenylethylamine upon isolated rat aortic strip. NE, VSM
27  1980 Monoamine oxidase inhibitors potentiate phenylethylamine effects in rhesus monkeys. MAOI
28  1980 Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls. PAA
29  1980 Studies on human placental monoamine oxidase using mixed substrates. MAO
30  1980 Studies on lung N-methyltransferases, a pharmacological approach. beta-PE, PNMT
31  1980 [Clinical, biochemical and psychopharmacologic correlates in patients with depressive symptomatology]. MHPG
32  1981 A study on the acute effect of amphetamine on the urinary excretion of biogenic amines and metabolites in monkeys. DOPAC, MHPG, PAA, VMA
33  1981 Behavioural effects of acute and chronic beta-phenylethylamine administration in the rat: evidence for the involvement of 5-hydroxytryptamine. ---
34  1981 beta-Phenylethylamine reversal of chlorpromazine-induced activation of striatal tyrosine hydroxylase and catalepsy. ---
35  1981 Central action of phenylethylamine in rats. ---
36  1981 Cross-cultural study of a biochemical abnormality in paranoid schizophrenia. ---
37  1981 Effect of hyperoxia on uptake and metabolism of 5-hydroxytryptamine and beta-phenylethylamine in rat lung: a sex difference. 5-HT, MAO
38  1981 Human brain monoamine oxidase: one molecular entity-multiple binding sites? 5-HT, BA, MAO
39  1981 Ontogenesis of uptake and deamination of 5-hydroxytryptamine, dopamine and beta-phenylethylamine in isolated perfused lung and lung homogenates from rats. 5-HT, MAO
40  1981 Oxidation of beta-phenylethylamine by both types of monoamine oxidase: examination of enzymes in brain and liver mitochondria of eight species. MAO
41  1981 Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B. 5-HT, MAO
42  1981 Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum. DA, MAO, pTA
43  1981 Uptake and metabolism of biogenic amines in the developing rabbit lung. ---
44  1982 Alterations in trace amine and trace acid concentrations in isolated aggressive mice. m-HPA, mTA, p-HPA, p-TA, PAA
45  1982 Conformational preferences of dopamine analogues for inhibition of norepinephrine N-methyltransferase. Conformationally defined adrenergic agents. 2AT, DA, NE, NMT, THIQ
46  1982 Different effects of behaviorally equipotent doses of amphetamine and methamphetamine on brain biogenic amines: specific increase of phenylethylamine by amphetamine. AMPH, mAMPH
47  1982 Effect of prolonged desmethylimipramine administration on the pulmonary clearance of 5-hydroxytryptamine and beta-phenylethylamine in rats. 5-HT, DM, MAO
48  1982 Effects of drugs interfering with the metabolism of octopamine on blood pressure of rats. PNMT, SBP
49  1982 Effects of local anesthetics on monoamine oxidase, and their membrane effects. 5-HT, MAO
50  1982 Enflurane, halothane, and isoflurane inhibit removal of 5-hydroxytryptamine from the pulmonary circulation. 5-HT
51  1982 Fluctuating high urinary phenylethylamine excretion rates in some bipolar affective disorder patients. ---
52  1982 Monoamine oxidase: to B or not to B? 5-HT, BA
53  1982 On the mechanism of the involvement of monoamine oxidase in catecholamine-stimulated prostaglandin biosynthesis in particulate fraction of rat brain homogenates: role of hydrogen peroxide. alpha-met-NA, DA, DOPA, DOPAC, DOPAL, DOPEG, GOD, MAO, NA, PG
54  1982 Physiologic effects and plasma kinetics of beta-phenylethylamine and its N-methyl homolog in the dog. ---
55  1982 Serotonin receptor blockade potentiates behavioural effects of beta-phenylethylamine. 5-HT
56  1983 beta-Phenylethylamine-, d-amphetamine-and l-amphetamine-induced place preference conditioning in rats. ---
57  1983 Comparison of central actions of intraventricularly administered octopamine, phenylethylamine and adrenaline in rats. ADR, OCT
58  1983 Comparison of the effects of beta-phenylethylamine and d-amphetamine on rat isolated atria. AMPH, NE
59  1983 Deuterium substitution enhances the effects of beta-phenylethylamine on spontaneous motor activity in the rat. ---
60  1983 Drug-induced changes in motor activity after selective MAO inhibition. ---
61  1983 Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone. DA, DOPAC
62  1983 Evidence for the localization of hydrogen peroxide-stimulated cyclooxygenase activity in rat brain mitochondria: a possible coupling with monoamine oxidase. GOD, MAO, NA, RSA, SDH
63  1983 Human brain monoamine oxidase: solubilization and kinetics of inhibition by octylglucoside. 5-HT, MAO, OG, TYR
64  1983 In vivo, noradrenaline is a substrate for rat brain monoamine oxidase A and B. 5-HT, MAO, NA
65  1983 Influence of formamidines on biogenic amine levels in rat brain and plasma. 5-HT, CDF, DA, NE, PCA, TRM
66  1983 Intestinal contribution to the presystemic elimination of beta-phenethylamine in the rat. ---
67  1983 Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment. 5-HIAA, CSF, HVA, MHPG
68  1983 Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls. CSF, PAA
69  1983 Studies in the mechanism of phenylethylamine uptake by rabbit erythrocytes. ---
70  1983 Synthesis and monoamine oxidase inhibitory activities of alpha-allenic amines in vivo and in vitro. Different activities of two enantiomeric allenes. MAO
71  1983 The monoamine oxidase inhibiting properties of CGP 11305 A. 5-HT
72  1983 Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A. 3-MT, MN, NMN
73  1983 [Effect of beta-phenylethylamine on locomotor activity and brain catecholamine metabolism in mice]. DOPAC, HVA, MHPG
74  1984 Activation of monoamine oxidase by high molecular weight fractions of human plasma. MAO, RBM -MAO
75  1984 Amelioration of psychosis with carbidopa. A case report. ---
76  1984 Amino acid distribution in brain after use of amphetamines and beta-phenylethylamine. ---
77  1984 Behavior maintained under fixed-interval and second-order schedules by intravenous injections of endogenous noncatecholic phenylethylamines in dogs. FI, NMPEA
78  1984 Brain levels of 5-hydroxytryptamine, tryptamine and 2-phenylethylamine in the rat after administration of N-cyanoethyltranylcypromine. 5-HT
79  1984 Cannabis extract, but not delta 1-tetrahydrocannabinol, inhibits human brain and liver monoamine oxidase. BA, CE, MAO, THC, TLC
80  1984 Changes in cyclooxygenase activity and prostaglandin profiles during monoamine metabolism in rat brain homogenates. alpha metNA, MAO, NA, PG, TX, Tyr
81  1984 Characteristics of analgesia induced by noncatecholic phenylethylamine derivatives: possible involvement of endogenous opioid peptides and serotonin in phenylethylamine analog-induced analgesia. PCPA
82  1984 Depression during methadone withdrawal: no role for beta-phenylethylamine. ---
83  1984 Determination of 2-phenylethylamine in rat brain after MAO inhibitors, and in human CSF and urine by capillary GC and chemical ionization MS. MAO
84  1984 Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase. 5-HT, MAO
85  1984 Hypodipsia, stereotypy and hyperactivity induced by beta-phenylethylamine in the water-deprived rat. ---
86  1984 Pharmacogenetics of phenylethylamine: determination of heritability and genetic transmission of locomotor effects in recombinant inbred strains of mice. ---
87  1984 Phenylethylamine excretion in depression. PAA
88  1984 Potentiation of total horizontal activity and ambulation in rats treated with combinations of beta-phenylethylamine and naloxone. ---
89  1984 Properties of monoamine oxidase in monkey heart. CRAO, MAO
90  1984 Some properties of monoamine oxidase in carp heart. 5-HT, CRAO, MAO
91  1984 Urinary phenethylamine response to d-amphetamine in 12 boys with attention deficit disorder. ---
92  1984 [Antidepressive effects of 3 endogenous monoamines: psychopharmacologic profiles of noradrenaline, octopamine and phenethylamine]. NE, OA
93  1985 Biochemical effects of L-deprenyl in atypical depressives. MAO, MHPG
94  1985 Cold-restraint stress and urinary endogenous beta-phenylethylamine excretion in rats. ---
95  1985 Effects of L-dopa and L-tyrosine on release of free and conjugated dopamine, homovanillic acid and dihydroxyphenylacetic acid from slices of rat striatum. DOPAC
96  1985 Examination of the bronchoconstrictor response of guinea-pig isolated lung to beta-phenylethylamine. ---
97  1985 Inhibition of locus coeruleus neuronal activity by beta-phenylethylamine. alpha-MT, LC, MAO, NA
98  1985 Local application of beta-phenylethylamine to the caudate nucleus of the rat elicits locomotor stimulation. ---
99  1985 Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat. MAO
100  1985 Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine. MHPG, NE, NMN
101  1985 Visual evoked potential recordings in hepatic encephalopathy and their variations during branched chain amino-acid treatment. BCAA, HE, OCT, VEP
102  1985 [3H]-Flunitrazepam binding in the presence of beta-phenylethylamine and its metabolites. ---
103  1985 [Differences and similarity in the interaction of fenibut, baclofen and diazepam with phenylethylamine]. ---
104  1986 A behavioural and pharmacological examination of phenylethylamine-induced anorexia and hyperactivity--comparisons with amphetamine. AMPH
105  1986 Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. PAA
106  1986 Comparative lipophilicities of substrates of monoamine oxidase. 5-HT, MAO
107  1986 Determination of phenylacetic acid in cerebrospinal fluid by gas chromatography-mass spectrometry. CSF, PAA
108  1986 Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation. ---
109  1986 Discriminative stimulus properties of beta-phenylethylamine, deuterated beta-phenylethylamine, phenylethanolamine and some metabolites of phenylethylamine in rodents. NMPEA, NMPEOH, PEOH
110  1986 Electron-capture gas chromatographic analysis of beta-phenylethylamine in tissues and body fluids using pentafluorobenzenesulfonyl chloride for derivatization. ---
111  1986 In vivo release of endogenous dopamine from rat caudate nucleus by beta-phenylethylamine and alpha,alpha,-dideutero-beta-phenylethylamine. DA
112  1986 Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 A. MAO-B, MAOA
113  1986 Monoamine oxidase in bovine thyroid tissue. 5-HT, MAO
114  1986 Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder. 5-HIAA
115  1986 Pharmacological changes induced by repeated exposure to phenylethylamine. ---
116  1986 The effect of repeated administration of (-) deprenyl on the phenylethylamine-induced stereotypy in rats. ---
117  1986 Urinary phenylethylamine correlates positively with hypomania, and negatively with depression, paranoia, and social introversion on the MMPI. ---
118  1986 [beta Phenylethylamine: psychopharmacological and clinical aspects]. ---
119  1987 Behaviourally specific interactions between naloxone and beta-phenylethylamine in an operant drug discrimination procedure in rats. ---
120  1987 Effects of beta-phenylethylamine on locomotor activity, body temperature and ethanol blood concentrations during acute ethanol intoxication. SLA
121  1987 Monoamine oxidase activities in lymphocytes and granulocytes taken from pig blood. BZ, SSAO
122  1987 N,N-dipropargyl-2-phenylethylamine, a potential prodrug of 2-phenylethylamine: neurochemical and neuropharmacological studies in rat. DPGPEA
123  1987 N-(3-chloropropyl)phenylethylamine as a possible prodrug of beta-phenylethylamine: studies in the rat brain. CPPEA
124  1987 N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl. 5-HT, MAO, NA, NPB
125  1987 Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine. CEPEA, GC-ECD, HPLC-EC
126  1987 Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients. CSF, Phe
127  1987 Radioenzymatic analysis of neurotransmitters. DA, NE, OA, PEOHA, TA
128  1987 RS-2232, a compound with a reversible and specific type-A monoamine oxidase inhibiting property in mouse brain. 5-HT, MAO
129  1987 Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia. MAO, PAA
130  1987 [Review and updating of the diagnostic sensibility of the dexamethasone suppression test and urinary determination of phenylethylamine and 3-methoxy-4-hydroxyphenylethylglycol in the diagnosis of endogenous depression]. MHPG
131  1988 Characteristics of antinociception induced by noncatecholic phenylethylamine derivatives: the relation of endogenous norepinephrine to phenylethylamine analog-induced antinociception. ---
132  1988 Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. AMPH, DOPAC, NOM, NU, OCT, TYR
133  1988 Determination of beta-phenylethylamine in catfish (Parasilurus asotus) tissues by gas chromatography/mass spectrometry. ---
134  1988 Increase in urinary beta-phenylethylamine preceding the switch from mania to depression: a "rapid cycler". ---
135  1988 Phenylethylamine-induced taste aversion in rats and mice. AMP, CTA
136  1988 Properties of a semicarbazide-sensitive amine oxidase in human umbilical artery. 5-HT, MAO, SSAO
137  1989 Characterization of monoamine oxidase activity present in human granulocytes and lymphocytes. 5-HT, BZ, MAO, SSAO, TYR
138  1989 Comparative studies of the effects of RS-8359 and safrazine on monoamine oxidase in-vitro and in-vivo in mouse brain. 5-HT, MAO
139  1989 Effects of phenylethylamine on rat locomotor behavior and avoidance learning. MAO-B
140  1989 Enhancement of spinal monosynaptic reflexes with phenylethylamine and related drugs through descending noradrenergic neurons. 5,6-DHT, MSR
141  1989 Monoamine oxidase (MAO) in pancreatic islets of the mouse: some characteristics and the effect of chemical sympathectomy. DA, ies, MAO
142  1989 Recovery of MAO-B enzyme activity after (-)deprenyl (selegiline) pretreatment, measured in vivo. ---
143  1989 Some characteristics of mitochondrial monoamine oxidase activity in eggs of carp (Cyprinus carpio) and rainbow trout (Salmo gairdneri). 5-HT, MAO
144  1989 Structure-activity relationships of phenylethylamine analogs in their serotonergic depressant effects on the spinal monosynaptic reflex in rats. 5-HT, MSR
145  1989 The most desirable conformation of phenylethylamine (PEA) moiety stimulating noradrenergic neurons: effects of PEA, methamphetamine, phenelzine, methylphenidate, nomifensine and mazindol on rat spinal reflexes. MSR
146  1989 [beta-Phenylethylamine and amphetamine: similar aspects in their behavioropharmacological and neurochemical characteristics]. AMP
147  1990 Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat. DA, DOPAC
148  1990 Beta-phenylethylamine (PEA): an endogenous anxiogen? Three series of experimental data. ---
149  1990 Gastric mucosal protection with beta-phenylethylamine (PEA) and other sympathomimetic amines against absolute ethanol in the rat. ---
150  1990 Monoamine oxidase A mediates iodotyrosine formation induced by monoamines in bovine thyroid particulate fraction. 5-HT, MAO
151  1990 Monoamine oxidase activity in embryos of pike (Esox lucius). 5-HT
152  1990 Phenylalanine and its metabolites induce embryopathies in mouse embryos in culture. 2-OH PAA, NTDs, PAA, Phe, PLA, PPA
153  1990 Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures. 5-HIAA, MAO
154  1990 Urinary amines in Tourette's syndrome patients with and without phenylethylamine abnormality. ---
155  1991 Effect of L-dopa administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse. HRP, L-DOPA, MAO
156  1991 Inhibitory effects of beta-phenylethylamine on photic-evoked potentials in the visual cortex of the cat. ---
157  1991 Neuropsychological performance and urinary phenylethylamine in Tourette's syndrome. TS
158  1991 Phenylethylaminergic mechanisms in attention-deficit disorder. ADHD, PAA, Phe, Tyr
159  1991 The response to acoustic stimulation and the changes in brain amine levels after repeated administration of beta-phenylethylamine in rats. ---
160  1992 (-)Deprenyl-medication: a strategy to modulate the age-related decline of the striatal dopaminergic system. MAO, SOD
161  1992 Beta-phenylethylamine and noradrenergic function in depression. MHPG
162  1992 Determination of urinary beta-phenylethylamine as its N-benzenesulphonamide derivative by gas chromatography with flame photometric detection. GC
163  1992 Pharmacological basis of the therapeutic effect of (-)deprenyl in age-related neurological diseases. MAO, SOD
164  1992 The pharmacological profile of (-)deprenyl (selegiline) and its relevance for humans: a personal view. MAO
165  1993 2-Phenylethylamine-induced changes in catecholamine receptor density: implications for antidepressant drug action. DA, MAOI
166  1993 Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes. MAO
167  1993 Characteristics of antinociception induced by noncatecholic phenylethylamine derivatives: the involvement of alpha-2-adrenoceptors. ---
168  1993 Formation of a new 1,1,1 adduct in the reaction of malondialdehyde, n-hexylamine and alkanal under neutral conditions. HA, MDA
169  1993 Further proof that (-)deprenyl fails to facilitate mesolimbic dopaminergic activity. AM, DA, MAO
170  1993 Glucose modulation of islet monoamine oxidase activity in lean and obese hyperglycemic mice. DA, MAO
171  1993 Pharmacological sensitivity of the articular capsule of the primary spines of Eucidaris tribuloides. ACh, CCh, MeACh
172  1993 Platelet monoamine oxidase B activity in Parkinson's disease: a re-evaluation. MAO
173  1993 Simultaneous determination of methamphetamine and its metabolites in the urine samples of abusers by high performance liquid chromatography with chemiluminescence detection. AP, EP, MA, NE, pOHAP, pOHMA
174  1993 The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases. MAO, SOD
175  1993 Trace amines and Tourette's syndrome. IAA, TS, TSGS
176  1993 Urinary excretion of bioactive amines and their metabolites in psychiatric patients receiving phenelzine. 3-MT, 5-HIAA, 5-HT, HVA, m- and p-OH-PAA, m- and p-TA, MAO, MHPG, NME, PAA
177  1994 Chiral separation of amines by high-performance liquid chromatography after tagging with 4-(N,N-dimethylaminosulphonyl)-7-(2-chloroformylpyrrolidin-1-yl)- 2,1,3-benzoxadiazole. CEA
178  1994 Cloning of a novel monoamine oxidase cDNA from trout liver. MAO
179  1994 Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline. MAO-B, MAOA
180  1994 Phenylethylamine and schizophrenia. ---
181  1994 Role of conductivity in iontophoresis. 2. Anodal iontophoretic transport of phenylethylamine and sodium across excised human skin. ---
182  1994 The measurement of beta-phenylethylamine in human plasma and rat brain. PPA
183  1995 Phenylethylamine modulation of affect: therapeutic and diagnostic implications. ---
184  1995 Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes. MAO, SOD
185  1995 Regions of the molecule responsible for substrate specificity of monoamine oxidase A and B: a chimeric enzyme analysis. ---
186  1995 Selectivity of MDL 72,974A for MAO-B inhibition based on substrate and metabolite concentrations in plasma. DA, DOPA, DOPAC, DOPEG, NA
187  1995 [Platelet serotonin in endogenous depressive patients and normal controls]. PAA
188  1996 Antagonism by CPP (+/-)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, of beta-phenylethylamine (PEA)-induced hypermotility in mice of different strains. AP5, AP7, i.c.v, NMDA
189  1996 Determination of the enantiomeric composition of chiral amines based on the quenching of the fluorescence of a chiral calixarene. ---
190  1996 Identification of a region important for human monoamine oxidase B substrate and inhibitor selectivity. MAO
191  1996 Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain. CAE, DMI
192  1996 Sensitive high-performance liquid chromatographic method for the determination of 2-phenylethylamine in human urine. HPLC, MAO-B
193  1996 Sustained antidepressant effect of PEA replacement. ---
194  1997 A kinetic analysis of the effects of beta-phenylethylamine on the concentrations of dopamine and its metabolites in the rat striatum. DA, DOPAC, HVA, MAO-B
195  1997 Decreased beta-phenylethylamine in CSF in Parkinson's disease. ---
196  1997 Effects of the administration of amphetamine, either alone or in combination with reserpine or cocaine, on regional brain beta-phenylethylamine and dopamine release. 3-MT, AMPH, DA
197  1997 Increased stress response and beta-phenylethylamine in MAOB-deficient mice. DA, NE
198  1997 Modulation of the inhibitory effect of phenylethylamine on spontaneous motor activity in mice by CPP-(+/-)-3-(2-carboxypiperazin-4-YL)-propyl-1-phosphonic acid. MAO-B, NMDA, PCA
199  1997 [History of deprenyl--the first selective inhibitor of monoamine oxidase type B]. MAO, SOD
200  1998 Antagonism of kynurenic acid to anxiogens in mice. ---
201  1998 Effects of amphetamine and phenylethylamine on catecholamine release in the glomerular layer of the rat olfactory bulb. AMPH, CA, DA, GL, NA, OB
202  1998 Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid. AMPA, NMDA
203  1998 Monoamine oxidase activities in catfish (Parasilurus asotus) tissues. 5-HT, MAO
204  1999 (-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. ---
205  1999 Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitochondrial fraction. 1MeTIQ, MPTP
206  1999 Cerebral cortical blood flow maps are reorganized in MAOB-deficient mice. CBF, MAO-B
207  1999 Developmental aspects of cerebrospinal fluid levels of beta-phenylethylamine and it's role in pediatric neurological disorders. CSF, RS
208  1999 Role of MAO A and B in neurotransmitter metabolism and behavior. DA, KO, MAO, NE
209  1999 [Neurochemical and neurotransmitter studies in patients with learning disabilities]. ADHD, LD, MHPG
210  2000 Aromatic monoamine-induced immediate oxidative burst leading to an increase in cytosolic Ca2+ concentration in tobacco suspension culture. AOS
211  2000 Decreased cerebrospinal fluid levels of beta-phenylethylamine in patients with Rett syndrome. ---
212  2000 Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells. CHO, DA, DTT, L-DOPA
213  2000 Effects of beta-phenylethylamine on the hypothalamo-pituitary-adrenal axis in the male rat. ACTH, CRH, HPA, ME
214  2000 Phenylethylamine-induced generation of reactive oxygen species and ascorbate free radicals in tobacco suspension culture: mechanism for oxidative burst mediating Ca2+ influx. AOS, HRP, MDA
215  2000 Plasma beta-phenylethylamine in Parkinson's disease. PD
216  2000 Quantitation of low molecular mass substrates and products of enzyme catalyzed reactions using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. BzA, MET
217  2001 2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity. MAO
218  2001 Apical dominance in Pssu-ipt-transformed tobacco. AAs, CKs, PA, Put, Spd, Spm, TYR
219  2001 Application of automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the measurement of enzyme activities. EMA, GC, MALDI-TOF MS, MET
220  2001 Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug. ---
221  2001 Platelet monoamine oxidase B and plasma beta-phenylethylamine in Parkinson's disease. GC-MS, MAO-B
222  2001 Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. CAE/SAE
223  2002 1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged. ---
224  2002 Diastereomeric salts of lactic acid and 1-phenylethylamine, their structures and relative stabilities. S-LA, S-LA
225  2002 Monoamine-dependent production of reactive oxygen species catalyzed by pseudoperoxidase activity of human hemoglobin. Hb, ROS
226  2002 Phenylethylamine induces an increase in cytosolic Ca2+ in yeast. ---
227  2002 Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease. MAO
228  2002 [Decreased beta-phenylethylamine in urine of children with attention deficit hyperactivity disorder and autistic disorder]. 5-HIAA, AD, ADHD, HVA, MHPG
229  2002 [Human striatal D-neurons and their significance]. AADC, DA, NA, TH, TPH
230  2002 [Localization of non-monoaminergic aromatic L-amino acid decarboxylase neurons (D-neurons) in the human striatum and their functional significance]. AADC, D-neurons, D-neurons
231  2002 [Neuroimaging and neurochemical studies of Rett syndrome]. MeCP2, RTT
232  2003 A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition. 5-HIAA, AMT, DMS, GC-MS, GLC, HPLC, MAO-A, MAO-B, MET
233  2003 An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug. 5-HT, MAO, MAO-A, RIZ
234  2003 Effects of monoamines formed in the cecum of horses on equine digital blood vessels and platelets. 5-HT, IAA, IBA, TRP, TYR
235  2003 Seasonal changes in plasma concentrations of cecum-derived amines in clinically normal ponies and ponies predisposed to laminitis. HPLC, IAA, TRP, TYR
236  2003 Semicarbazide-sensitive amine oxidases in pig dental pulp. 5-HT, SSAO
237  2004 Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B. DA, NE
238  2004 Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery. 5-HIAA, MAO
239  2004 Pharmacological studies with endogenous enhancer substances: beta-phenylethylamine, tryptamine, and their synthetic derivatives. MAO, TAs
240  2004 Significance of human striatal D-neurons: implications in neuropsychiatric functions. AADC, ACC
241  2005 2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice. ---
242  2005 A rapid, sensitive electron-capture gas chromatographic procedure for analysis of metabolites of N-methyl,N-propargylphenylethylamine, a potential neuroprotective agent. MPPE, N-methylPEA, N-propargylPEA, PFBSC
243  2005 Experimental and modelization approach in the study of acid-site energy distribution by base desorption. Part I: modified silica surfaces. TGA
244  2005 Primate trace amine receptor 1 modulation by the dopamine transporter. MDMA
245  2006 Simultaneous liquid chromatography determination of polyamines and arylalkyl monoamines. DA, DAP, Put, SAL, Spd, Spm, TYR
246  2007 Comparative study of charge division in substituted benzene cations. PB, PEAL, PPA
247  2007 Conformational study of tyramine and its water clusters by laser spectroscopy. ---
248  2007 Simultaneous determination of 13 amphetamine related drugs in human whole blood using an enhanced polymer column and gas chromatography-mass spectrometry. MA, MDA, MDMA, ME, PMA
249  2007 Synthesis, structures, and optical properties of cadmium iodide/phenethylamine hybrid materials with controlled structures and emissions. CdI2
250  2007 Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine. AMPH, HEK, METH, mTAAR1, p-OHA, rTAAR1, TAs, TYR
251  2007 Trace amine-associated receptor 1-Family archetype or iconoclast? AMPH, cAMP, DA, GPCR, OCT, SYN, TA, TAAR, TAR1, Tryp, TYR
252  2008 Chiral mono and diamide derivatives of calix[4]arene for enantiomeric recognition of chiral amines. ---
253  2008 Escherichia coli NsrR regulates a pathway for the oxidation of 3-nitrotyramine to 4-hydroxy-3-nitrophenylacetate. NO
254  2008 [A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508]. CAR
255  2009 A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. ---
256  2009 Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. KO, MAO, TAAR1, WT
257  2009 Intramolecular interactions of L-phenylalanine revealed by inner shell chemical shift. PPA
258  2010 2-Phenylethylamine, a constituent of chocolate and wine, causes mitochondrial complex-I inhibition, generation of hydroxyl radicals and depletion of striatal biogenic amines leading to psycho-motor dysfunctions in Balb/c mice. ---
259  2010 A 4-hydroxy-N'-[(E)-(2-hydroxyphenyl)methylidene]benzohydrazide-based sorbent material for the extraction-HPLC determination of biogenic amines in food samples. BAs, Cad, HIS, Put, Spd, TRY, TYR
260  2010 Selective electrochemical discrimination between dopamine and phenethylamine-derived psychotropic drugs using electrodes modified with an acyclic receptor containing two terminal 3-alkoxy-5-nitroindazole rings. AMPH, DA, HOM, MES, METH, PMA
261  2010 Transport of phenylethylamine at intestinal epithelial (Caco-2) cells: mechanism and substrate specificity. ---
262  2011 Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. MAO
263  2011 Conformational equilibrium and hydrogen bonding in liquid 2-phenylethylamine explored by Raman spectroscopy and theoretical calculations. ---
264  2011 Detection of the reaction intermediates catalyzed by a copper amine oxidase. AGAO
265  2011 Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists. ADRB1, GPCR, OA, TAAR, TAR, TYR
266  2012 Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. ADHD, DHEA, HPA, MAO, MHPG, NE, NPY, Zn
267  2012 Effects of fluorine substitution on the shape of neurotransmitters: the rotational spectrum of 2-(2-fluorophenyl)ethanamine. ---
268  2012 Immobilization of Escherichia coli containing omega-transaminase activity in LentiKats. Ala, APB, CTAB, IPA, omega-TA
269  2012 Tyramine and phenylethylamine biosynthesis by food bacteria. PLP, TDC
270  2013 beta-phenylethylamine, a small molecule with a large impact. ---
271  2013 Coupled electron-nuclear dynamics: charge migration and charge transfer initiated near a conical intersection. ---
272  2013 Effect of fluazifop-p-butyl treatment on pigments and polyamines level within tissues of non-target maize plants. ACCase, ANC, FL, LDC, ODC, TYDC
273  2013 Enantiomeric fraction determination of 2-arylpropionic acids in a package plant membrane bioreactor. 2-APA, EFs, MBR
274  2013 New phenethylamine derivatives from Arenibacter nanhaiticus sp. nov. NH36A(T) and their antimicrobial activity. ---
275  2013 Relative quantification of enantiomers of chiral amines by high-throughput LC-ESI-MS/MS using isotopic variants of light and heavy L-pyroglutamic acids as the derivatization reagents. L-PGA, MRM
276  2013 [Localization and functions of the D-neuron: significance in pathogenesis of schizophrenia]. AADC, DA, LSD, MDMA, TAAR1, TAs, VTA
277  2014 Analgesic effects of beta-phenylethylamine and various methylated derivatives in mice. ---
278  2014 LC-MS-MS analysis of dietary supplements for N-ethyl-alpha-ethyl-phenethylamine (ETH), N, N-diethylphenethylamine and phenethylamine. ETH, LC-MS-MS, WADA
279  2014 Modulation of resistance artery tone by the trace amine beta-phenylethylamine: dual indirect sympathomimetic and alpha1-adrenoceptor blocking actions. ---
280  2014 ss-Phenylethylamine as a novel nutrient treatment to reduce bacterial contamination due to Escherichia coli O157:H7 on beef meat. AAA
281  2015 A beating heart cell model to predict cardiotoxicity: effects of the dietary supplement ingredients higenamine, phenylethylamine, ephedrine and caffeine. bpm
282  2015 A monoclonal antibody based enzyme-linked immunosorbent assay for detection of phenylethanolamine A in tissue of swine. cBSA, ELISA, McAb
283  2015 Amino acid conversions by coagulase-negative staphylococci in a rich medium: Assessment of inter- and intraspecies heterogeneity. CNS, SH-GC-MS
284  2015 Aspergillus oryzae pathways that convert phenylalanine into the flavor volatile 2-phenylethanol. AadA, PE
285  2015 Behavioral effects of beta-phenylethylamine and various monomethylated and monohalogenated analogs in mice are mediated by catecholaminergic mechanisms. ---
286  2015 Revealing Monoamine Oxidase B Catalytic Mechanisms by Means of the Quantum Chemical Cluster Approach. BA, MAO-B, NBA
287  2015 Superparamagnetic core-shells anchored onto graphene oxide grafted with phenylethyl amine as a nano-adsorbent for extraction and enrichment of organophosphorus pesticides from fruit, vegetable and water samples. FTIR, GC-NPD, GO, MSPE, OPPs, RSDs, SEM, VSM
288  2016 Conformational distortion of alpha-phenylethyl amine in cryogenic matrices - a matrix isolation VCD study. PES, VCD
289  2016 Nuclear spatial delocalization silences electron density oscillations in 2-phenyl-ethyl-amine (PEA) and 2-phenylethyl-N,N-dimethylamine (PENNA) cations. PENNA
290  2016 Olsalazine-Based Metal-Organic Frameworks as Biocompatible Platforms for H2 Adsorption and Drug Delivery. ---
291  2016 Publisher's Note: "Nuclear spatial delocalization silences electron density oscillations in 2-phenyl-ethyl-amine (PEA) and 2-phenylethyl-N,N-dimethylamine (PENNA) cations" [J. Chem. Phys. 144, 104110 (2016)]. PENNA
292  2016 The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015). CAE, DEP
293  2017 A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain. BPAP, CAE, DEP, TMS, VMAT2
294  2017 Accumulation and Determination of Phenylethanolamine A Residue in Hair of Swine and Sheep. ---
295  2017 Biosensor for the characterisation of hMAO B inhibitors and the quantification of selegiline. FIA, hMAO-B
296  2017 Multiscale simulation of monoamine oxidase catalyzed decomposition of phenylethylamine analogs. EVB, MAO, p-CMP, p-MMP
297  2017 The Effect of Experimental Supplementation with the Klamath Algae Extract Klamin on Attention-Deficit/Hyperactivity Disorder. ADHD
298  2018 A sensitive, high-throughput LC-MS/MS method for measuring catecholamines in low volume serum. EPI, MN, MRM, NE, NMN, PITC
299  2018 Air-Stable and Self-Driven Perovskite Photodiodes with High On/Off Ratio and Swift Photoresponse. DMSO, RP
300  2018 Cell-Based Biosensor with Dual Signal Outputs for Simultaneous Quantification of Phenylacetic Acid and Phenylethylamine. PA
301  2018 Efficacy of beta-phenylethylamine as a novel anti-microbial and application as a liquid catheter flush. ATP
302  2018 Non-adrenergic vasoconstriction and vasodilatation of guinea-pig aorta by beta-phenylethylamine and amphetamine - Role of nitric oxide determined with L-NAME and NO scavengers. L-NAME, NO, TAAR
303  2018 Why does the Y326I mutant of monoamine oxidase B decompose an endogenous amphetamine at a slower rate than the wild type enzyme? Reaction step elucidated by multiscale molecular simulations. MAO-B
304  2019 Simultaneous determination of beta-agonists on hexagonal boron nitride nanosheets/multi-walled carbon nanotubes nanocomposite modified glassy carbon electrode. AA, CLE, CV, EIS, f-MWCNTs, GCE, LOD, RAC, SAL, SEM, UA, XRD